• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 610
  • 522
  • 506
  • Tagged with
  • 1634
  • 1634
  • 1609
  • 1071
  • 1069
  • 1040
  • 898
  • 894
  • 855
  • 855
  • 855
  • 847
  • 833
  • 830
  • 827
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
111

Amygdala fMRI Signal as a Predictor of Reaction Time

Riedel, Philipp, Jacob, Mark J., Müller, Dirk K., Vetter, Nora C., Smolka, Michael N., Marxen, Michael 10 January 2017 (has links) (PDF)
Reaction times (RTs) are a valuable measure for assessing cognitive processes. However, RTs are susceptible to confounds and therefore variable. Exposure to threat, for example, speeds up or slows down responses. Distinct task types to some extent account for differential effects of threat on RTs. But also do inter-individual differences like trait anxiety. In this functional magnetic resonance imaging (fMRI) study, we investigated whether activation within the amygdala, a brain region closely linked to the processing of threat, may also function as a predictor of RTs, similar to trait anxiety scores. After threat conditioning by means of aversive electric shocks, 45 participants performed a choice RT task during alternating 30 s blocks in the presence of the threat conditioned stimulus [CS+] or of the safe control stimulus [CS-]. Trait anxiety was assessed with the State-Trait Anxiety Inventory and participants were median split into a high- and a low-anxiety subgroup. We tested three hypotheses: (1) RTs will be faster during the exposure to threat compared to the safe condition in individuals with high trait anxiety. (2) The amygdala fMRI signal will be higher in the threat condition compared to the safe condition. (3) Amygdala fMRI signal prior to a RT trial will be correlated with the corresponding RT. We found that, the high-anxious subgroup showed faster responses in the threat condition compared to the safe condition, while the low-anxious subgroup showed no significant difference in RTs in the threat condition compared to the safe condition. Though the fMRI analysis did not reveal an effect of condition on amygdala activity, we found a trial-by-trial correlation between blood-oxygen-level-dependent signal within the right amygdala prior to the CRT task and the subsequent RT. Taken together, the results of this study showed that exposure to threat modulates task performance. This modulation is influenced by personality trait. Additionally and most importantly, activation in the amygdala predicts behavior in a simple task that is performed during the exposure to threat. This finding is in line with “attentional capture by threat”—a model that includes the amygdala as a key brain region for the process that causes the response slowing.
112

Compile- and run-time approaches for the selection of efficient data structures for dynamic graph analysis

Schiller, Benjamin, Deusser, Clemens, Castrillon, Jeronimo, Strufe, Thorsten 11 January 2017 (has links) (PDF)
Graphs are used to model a wide range of systems from different disciplines including social network analysis, biology, and big data processing. When analyzing these constantly changing dynamic graphs at a high frequency, performance is the main concern. Depending on the graph size and structure, update frequency, and read accesses of the analysis, the use of different data structures can yield great performance variations. Even for expert programmers, it is not always obvious, which data structure is the best choice for a given scenario. In previous work, we presented an approach for handling the selection of the most efficient data structures automatically using a compile-time approach well-suited for constant workloads. We extend this work with a measurement study of seven data structures and use the results to fit actual cost estimation functions. In addition, we evaluate our approach for the computations of seven different graph metrics. In analyses of real-world dynamic graphs with a constant workload, our approach achieves a speedup of up to 5.4× compared to basic data structure configurations. Such a compile-time based approach cannot yield optimal results when the behavior of the system changes later and the workload becomes non-constant. To close this gap we present a run-time approach which provides live profiling and facilitates automatic exchanges of data structures during execution. We analyze the performance of this approach using an artificial, non-constant workload where our approach achieves speedups of up to 7.3× compared to basic configurations.
113

New Concept of Polymethyl Methacrylate (PMMA) and Polyethylene Terephthalate (PET) Surface Coating by Chitosan

Wieckiewicz, Mieszko, Wolf, Eric, Richter, Gert, Meissner, Heike, Boening, Klaus 06 January 2017 (has links) (PDF)
Chitosan is known for its hemostatic and antimicrobial properties and might be useful for temporary coating of removable dentures or intraoral splints to control bleeding after oral surgery or as a supportive treatment in denture stomatitis. This study investigated a new method to adhere chitosan to polymethyl methacrylate (PMMA) and polyethylene terephthalate (PET). There were 70 cylindrical specimens made from PMMA and 70 from PET (13 mm diameter, 6 mm thickness). The materials with ten specimens each were sandblasted at 2.8 or 4.0 bar with aluminum oxide 110 μm or/and aluminum oxide coated with silica. After sandblasting, all specimens were coated with a 2% or 4% acetic chitosan solution with a thickness of 1 mm. Then the specimens were dried for 120 min at 45 °C. The precipitated chitosan was neutralized with 1 mol NaOH. After neutralization, all specimens underwent abrasion tests using the tooth-brushing simulator with soft brushes (load 2N, 2 cycles/s, 32 °C, 3000 and 30,000 cycles). After each run, the specimen surfaces were analyzed for areas of remaining chitosan by digital planimetry under a light microscope. The best chitosan adhesion was found after sandblasting with aluminum oxide coated with silica (U-Test, p < 0.05) in both the PMMA and the PET groups. Hence, with relatively simple technology, a reliable bond of chitosan to PMMA and PET could be achieved.
114

New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies

Sehr, Tony, Proschmann, Undine, Thomas, Katja, Marggraf, Michaela, Straube, Elmar, Reichmann, Heinz, Chan, Andrew, Ziemssen, Tjalf 17 November 2016 (has links) (PDF)
Background The monoclonal antibody natalizumab (NAT) inhibits the migration of lymphocytes throughout the blood–brain barrier by blocking very late antigen (VLA)-4 interactions, thereby reducing inflammatory central nervous system (CNS) activity in patients with multiple sclerosis (MS). We evaluated the effects of different NAT treatment regimens. Methods We developed and optimised a NAT assay to measure free NAT, cell-bound NAT and VLA-4 expression levels in blood and cerebrospinal fluid (CSF) of patients using standard and prolonged treatment intervals and after the cessation of therapy. Results In paired CSF and blood samples of NAT-treated MS patients, NAT concentrations in CSF were approximately 100-fold lower than those in serum. Cell-bound NAT and mean VLA-4 expression levels in CSF were comparable with those in blood. After the cessation of therapy, the kinetics of free NAT, cell-bound NAT and VLA-4 expression levels differed. Prolonged intervals greater than 4 weeks between infusions caused a gradual reduction of free and cell-bound NAT concentrations. Sera from patients with and without NAT-neutralising antibodies could be identified in a blinded assessment. The NAT-neutralising antibodies removed NAT from the cell surface in vivo and in vitro. Intercellular NAT exchange was detected in vitro. Conclusions Incorporating assays to measure free and cell-bound NAT into clinical practice can help to determine the optimal individual NAT dosing regimen for patients with MS.
115

T Wave Amplitude Correction of QT Interval Variability for Improved Repolarization Lability Measurement

Schmidt, Martin, Baumert, Mathias, Malberg, Hagen, Zaunseder, Sebastian 19 January 2017 (has links) (PDF)
Objectives: The inverse relationship between QT interval variability (QTV) and T wave amplitude potentially confounds QT variability assessment. We quantified the influence of the T wave amplitude on QTV in a comprehensive dataset and devised a correction formula. Methods: Three ECG datasets of healthy subjects were analyzed to model the relationship between T wave amplitude and QTV. To derive a generally valid correction formula, linear regression analysis was used. The proposed correction formula was applied to patients enrolled in the Evaluation of Defibrillator in Non-Ischemic Cardiomyopathy Treatment Evaluation trial (DEFINITE) to assess the prognostic significance of QTV for all-cause mortality in patients with non-ischemic dilated cardiomyopathy. Results: A strong inverse relationship between T wave amplitude and QTV was demonstrated, both in healthy subjects (R2 = 0.68, p < 0.001) and DEFINITE patients (R2 = 0.20, p < 0.001). Applying the T wave amplitude correction to QTV achieved 2.5-times better group discrimination between patients enrolled in the DEFINITE study and healthy subjects. Kaplan-Meier estimator analysis showed that T wave amplitude corrected QTVi is inversely related to survival (p < 0.01) and a significant predictor of all-cause mortality. Conclusion: We have proposed a simple correction formula for improved QTV assessment. Using this correction, predictive value of QTV for all-cause mortality in patients with non-ischemic cardiomyopathy has been demonstrated.
116

To Sue and Make Noise' - Legal theatricality and civic didacticism in Boston Legal

Kanzler, Katja 08 April 2015 (has links)
The legal drama episode from which this dialogue is taken depicts an impossible case: a Sudanese immigrant, who lost most of his family to the violence in Darfur, wants to sue the U.S. government for failing to intervene in the face of obvious genocide. The case is unwinnable. Lori Colson’s construction of a legal basis for the case is more than shaky. But neither the client nor his lawyers expect to win the case. Their proclaimed objective – to “make noise” – pinpoints a significant cultural potential of litigation, of its “real” practice in the courtroom and, even more importantly, in its various forms of mass-medialization and fictionalization: to raise public awareness about instances of injustice, to educate the public and encourage civic debate.
117

A Global Approach for Quantitative Super Resolution and Electron Microscopy on Cryo and Epoxy Sections Using Self-labeling Protein Tags

Müller, Andreas, Neukam, Martin, Ivanova, Anna, Sönmez, Anke, Münster, Carla, Kretschmar, Susanne, Kalaidzidis, Yannis, Kurth, Thomas, Verbavatz, Jean-Marc, Solimena, Michele 04 April 2017 (has links)
Correlative light and electron microscopy (CLEM) is a powerful approach to investigate the molecular ultrastructure of labeled cell compartments. However, quantitative CLEM studies are rare, mainly due to small sample sizes and the sensitivity of fluorescent proteins to strong fixatives and contrasting reagents for EM. Here, we show that fusion of a self-labeling protein to insulin allows for the quantification of age-distinct insulin granule pools in pancreatic beta cells by a combination of super resolution and transmission electron microscopy on Tokuyasu cryosections. In contrast to fluorescent proteins like GFP organic dyes covalently bound to self-labeling proteins retain their fluorescence also in epoxy resin following high pressure freezing and freeze substitution, or remarkably even after strong chemical fixation. This enables for the assessment of age-defined granule morphology and degradation. Finally, we demonstrate that this CLEM protocol is highly versatile, being suitable for single and dual fluorescent labeling and detection of different proteins with optimal ultrastructure preservation and contrast.
118

New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies

Sehr, Tony, Proschmann, Undine, Thomas, Katja, Marggraf, Michaela, Straube, Elmar, Reichmann, Heinz, Chan, Andrew, Ziemssen, Tjalf 17 November 2016 (has links)
Background The monoclonal antibody natalizumab (NAT) inhibits the migration of lymphocytes throughout the blood–brain barrier by blocking very late antigen (VLA)-4 interactions, thereby reducing inflammatory central nervous system (CNS) activity in patients with multiple sclerosis (MS). We evaluated the effects of different NAT treatment regimens. Methods We developed and optimised a NAT assay to measure free NAT, cell-bound NAT and VLA-4 expression levels in blood and cerebrospinal fluid (CSF) of patients using standard and prolonged treatment intervals and after the cessation of therapy. Results In paired CSF and blood samples of NAT-treated MS patients, NAT concentrations in CSF were approximately 100-fold lower than those in serum. Cell-bound NAT and mean VLA-4 expression levels in CSF were comparable with those in blood. After the cessation of therapy, the kinetics of free NAT, cell-bound NAT and VLA-4 expression levels differed. Prolonged intervals greater than 4 weeks between infusions caused a gradual reduction of free and cell-bound NAT concentrations. Sera from patients with and without NAT-neutralising antibodies could be identified in a blinded assessment. The NAT-neutralising antibodies removed NAT from the cell surface in vivo and in vitro. Intercellular NAT exchange was detected in vitro. Conclusions Incorporating assays to measure free and cell-bound NAT into clinical practice can help to determine the optimal individual NAT dosing regimen for patients with MS.
119

Antibody response to Mycoplasma pneumoniae: protection of host and influence on outbreaks?

Dumke, Roger, Jacobs, Enno 10 January 2017 (has links)
In humans of all ages, the cell wall-less and genome-reduced species Mycoplasma pneumoniae can cause infections of the upper and lower respiratory tract. The well-documented occurrence of major peaks in the incidence of community-acquired pneumonia cases reported world-wide, the multifaceted clinical manifestations of infection and the increasing number of resistant strains provide reasons for ongoing interest in the pathogenesis of mycoplasmal disease. The results of recent studies have provided insights into the interaction of the limited virulence factors of the bacterium with its host. In addition, the availability of complete M. pneumoniae genomes from patient isolates and the development of proteomic methods for investigation of mycoplasmas have not only allowed characterization of sequence divergences between strains but have also shown the importance of proteins and protein parts for induction of the immune reaction after infection. This review focuses on selected aspects of the humoral host immune response as a factor that might influence the clinical course of infections, subsequent protection in cases of re-infections and changes of epidemiological pattern of infections. The characterization of antibodies directed to defined antigens and approaches to promote their induction in the respiratory mucosa are also preconditions for the development of a vaccine to protect risk populations from severe disease due to M. pneumoniae.
120

Amygdala Regulation Following fMRI-Neurofeedback without Instructed Strategies

Marxen, Michael, Jacob, Mark J., Müller, Dirk K., Posse, Stefan, Ackley, Elena, Hellrung, Lydia, Riedel, Philipp, Bender, Stephan, Epple, Robert, Smolka, Michael N. 10 January 2017 (has links)
Within the field of functional magnetic resonance imaging (fMRI) neurofeedback, most studies provide subjects with instructions or suggest strategies to regulate a particular brain area, while other neuro-/biofeedback approaches often do not. This study is the first to investigate the hypothesis that subjects are able to utilize fMRI neurofeedback to learn to differentially modulate the fMRI signal from the bilateral amygdala congruent with the prescribed regulation direction without an instructed or suggested strategy and apply what they learned even when feedback is no longer available. Thirty-two subjects were included in the analysis. Data were collected at 3 Tesla using blood oxygenation level dependent (BOLD)-sensitivity optimized multi-echo EPI. Based on the mean contrast between up- and down-regulation in the amygdala in a post-training scan without feedback following three neurofeedback sessions, subjects were able to regulate their amygdala congruent with the prescribed directions with a moderate effect size of Cohen’s d = 0.43 (95% conf. int. 0.23–0.64). This effect size would be reduced, however, through stricter exclusion criteria for subjects that show alterations in respiration. Regulation capacity was positively correlated with subjective arousal ratings and negatively correlated with agreeableness and susceptibility to anger. A learning effect over the training sessions was only observed with end-of-block feedback (EoBF) but not with continuous feedback (trend). The results confirm the above hypothesis. Further studies are needed to compare effect sizes of regulation capacity for approaches with and without instructed strategies.

Page generated in 0.0547 seconds